|
KMID : 0613320050110010054
|
|
Journal of the Korean Bone and Joint Tumor Soceity
2005 Volume.11 No. 1 p.54 ~ p.61
|
|
|
Granulocytic Sarcoma(Chloroma) in Leukemic Patients
|
|
Rhee Seung-Koo
Kang Yong-Koo
Park Won-Jong
Chung Yang-Guk
Lee Sang-Wook
Jeong Ji-Ho
|
|
|
Abstract
|
|
|
Purpose: The granulocytic sarcoma which developed in leukemic patients are quite rare and it will have bad prognosis, but it’s tumor pathogenesis and also their treatment are not yet established. Through this study we have tried to know their clinical course, prognosis and their end result of recent treatment.
Material and Methods: Total 20 patients of granulocytic sarcoma which were developed in total 2,197 leukemic patients from April, 1998 to September, 2004 were treated at the leukemic center and the orthopaedic department of St. Mary’s hospital, Catholic University of Korea, and followed them for 1~78 months(average 18 months).
Results: Total 20 cases of granulocytic sarcoma was found in 14 cases of total 1,331 acute myelocytic leukemic patients(AML), 4 cases of total 744 of chronic myelocytic leukemic patients(CML), and only one case in total 122 of acute biphenotype of leukemia. And so their occurrence rate in leukmic patients are actually 0.91%, total 20 cases of granulocytic sarcoma in total 2,197 leukemic patients at same period. Their ages are average 28.3 years(4~52 years), and male are predominant(13 cases) than female(7 cases). Single involvement was found in 11 cases but multiple lesions are in 9 cases, and spine, brain, extremities, chest, and pelvic bone are involved in frequency. The granulocytic sarcoma was developed in various stages of the leukemia, ie, 8 cases in complete remission of leukemia, and 12 cases in the treatment process of AML. The pathohistologic evaluation of granulocytic sarcoma was done in 6 cases which
was developed in their extremities, and confirmed numerous immature myeloblasts and lymphocytes mixed. The treatment of these granulocytic sarcoma was mainly limited for the treatment of leukemia by Glivac and massive steroid therapy(19cases) and also combined with the bone marrow transplantation(13 cases), but radiation therapy with average 3,500 rads in 15 cases out of total 20 sarcomas was also done, and followed them for average 17.5 months after development of granulocytic sarcomas. Finally their prognosis was so bad that 12 patients(60%) out of total 20 granulocytic sarcoma were dead in 6.5 months after sarcoma developed and we found the granulocytic sarcoma was more fatal if they are developed during the process of CML(mortality:100%(4/4cases).
Conclusion: The prognosis of granulocytic sarcomas in leukemic patients are quite fatal, and much more studies for their pathogenesis and ways of treatment should be performed continuously.
|
|
|
KEYWORD
|
|
|
Granulocytic sarcoma, Chloroma, Leukemia
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|